Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases.
alveolar macrophages
bronchoalveolar lavage
lung disease
monocytes
myeloid derived suppressor cells
tuberculosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
12
2021
accepted:
08
02
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
9
4
2022
Statut:
epublish
Résumé
Myeloid-derived suppressor cells (MDSC) have been identified in the peripheral blood and granulomas of patients with active TB disease, but their phenotype-, function-, and immunosuppressive mechanism- spectrum remains unclear. Importantly, the frequency and signaling pathways of MDSC at the site of disease is unknown with no indication how this compares to MDSC identified in peripheral blood or to those of related myeloid counterparts such as alveolar macrophages and monocytes. Most phenotypic and functional markers have been described in oncological studies but have not yet been validated in TB. Using a panel of 43 genes selected from pathways previously shown to contribute to tumor-derived MDSC, we set out to evaluate if the expression of these additional functional markers and properties may also be relevant to TB-derived MDSC. Differential expression was investigated between MDSC, alveolar macrophages and monocytes enriched from bronchoalveolar lavage fluid and peripheral blood of patients with active TB, patients with other lung diseases (OLD). Results demonstrated that anatomical compartments may drive compartment-specific immunological responses and subsequent MDSC immunosuppressive functions, demonstrated by the observation that MDSC and/or monocytes from PB alone can discriminate,
Identifiants
pubmed: 35356003
doi: 10.3389/fimmu.2022.839747
pmc: PMC8959218
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
839747Informations de copyright
Copyright © 2022 Kotze, van der Spuy, Leonard, Penn-Nicholson, Musvosvi, McAnda, Malherbe, Erasmus, Scriba, Koegelenberg, Allwood, Walzl and du Plessis.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Tuberculosis (Edinb). 2018 Jan;108:124-126
pubmed: 29523312
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1053-66
pubmed: 25275852
Sci Rep. 2016 Nov 17;6:36923
pubmed: 27853279
Oncoimmunology. 2018 Jul 30;7(10):e1494113
pubmed: 30288362
PLoS One. 2015 Apr 16;10(4):e0123772
pubmed: 25879532
Cell Immunol. 2021 Nov;369:104426
pubmed: 34469846
Front Immunol. 2021 Jun 01;12:676679
pubmed: 34149712
Am J Respir Crit Care Med. 2017 Aug 1;196(3):315-327
pubmed: 28146645
Nat Commun. 2017 Nov 10;8(1):1404
pubmed: 29123081
Am J Respir Crit Care Med. 2013 Sep 15;188(6):724-32
pubmed: 23885784
Eur J Immunol. 2012 Aug;42(8):2060-72
pubmed: 22653638
Annu Rev Immunol. 2004;22:599-623
pubmed: 15032590
Clin Exp Immunol. 2012 Mar;167(3):523-31
pubmed: 22288596
Am J Respir Cell Mol Biol. 2016 Dec;55(6):899-908
pubmed: 27509488
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Breast Cancer Res. 2008;10(6):R95
pubmed: 19014637
Cells. 2020 Feb 27;9(3):
pubmed: 32121014
Front Immunol. 2019 Dec 03;10:2826
pubmed: 31849990
Am J Respir Crit Care Med. 2019 Jan 15;199(2):243-246
pubmed: 30339766
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5243-8
pubmed: 17875751
J Clin Invest. 2015 Sep;125(9):3365-76
pubmed: 26325033
J Infect Dis. 2017 Dec 12;216(11):1444-1451
pubmed: 29029332
Front Immunol. 2018 Jan 04;8:1895
pubmed: 29354120
Cell Immunol. 2021 Jun;364:104359
pubmed: 33865151
PLoS One. 2015 May 20;10(5):e0127028
pubmed: 25992611
EBioMedicine. 2020 Mar;53:102670
pubmed: 32113158
Nat Rev Immunol. 2021 Aug;21(8):485-498
pubmed: 33526920
Innate Immun. 2013 Jun;19(3):328-36
pubmed: 23160385
Int J Cancer. 1996 Jul 29;67(3):333-8
pubmed: 8707405
Eur Respir Rev. 2015 Sep;24(137):505-9
pubmed: 26324812
JCI Insight. 2019 Jun 4;5:
pubmed: 31162143
Immunity. 2021 May 11;54(5):875-884
pubmed: 33979585
Cancer Immunol Res. 2017 Jan;5(1):3-8
pubmed: 28052991
Cancer Res. 2015 Oct 15;75(20):4292-301
pubmed: 26359460
Front Immunol. 2018 Oct 23;9:2417
pubmed: 30405617
Cancer Res. 2010 Jan 1;70(1):68-77
pubmed: 20028852
Annu Rev Immunol. 2001;19:93-129
pubmed: 11244032
Eur J Immunol. 2017 Jan;47(1):107-118
pubmed: 27861788
Curr Opin Immunol. 2010 Apr;22(2):238-44
pubmed: 20171075
J Innate Immun. 2018;10(5-6):407-413
pubmed: 29945134
Immunity. 2011 Dec 23;35(6):1023-34
pubmed: 22195750
J Clin Invest. 2019 Dec 2;129(12):5537-5552
pubmed: 31566578
Br J Cancer. 2019 Jan;120(1):16-25
pubmed: 30413826
Nat Rev Cancer. 2015 Apr;15(4):225-37
pubmed: 25801618
Front Immunol. 2019 Jun 19;10:1399
pubmed: 31275326
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Sci Immunol. 2016 Aug;1(2):
pubmed: 28417112
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067787
J Exp Med. 2015 Mar 9;212(3):351-67
pubmed: 25667306
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
Biochim Biophys Acta. 2005 Dec 30;1746(3):305-13
pubmed: 16289370
J Immunol. 2016 Apr 15;196(8):3470-8
pubmed: 26936880
J Immunol. 2020 Jan 1;204(1):212-223
pubmed: 31776206
Immunol Rev. 2008 Apr;222:162-79
pubmed: 18364001
Cell Mol Life Sci. 2016 Nov;73(21):4043-61
pubmed: 27236468
Front Immunol. 2017 Feb 07;8:93
pubmed: 28223985
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938